Consult Super-Specialist Doctors at CARE Hospitals
Updated on 6 January 2025
Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in young children, the elderly, and individuals with weakened immune systems.
HMPV was first identified in 2001, two decades ago. This virus is not as transmissible as COVID-19, but necessary precautions, like wearing a mask, covering one's mouth while sneezing or coughing, and washing hands frequently with soap, need to be taken to prevent the infection.
HMPV often causes symptoms similar to a cold, and it can lead to more severe illnesses such as bronchitis or pneumonia or exacerbation of chronic respiratory conditions such as asthma or COPD.
HMPV is a widespread virus and one of the leading causes of acute respiratory infections globally. Most people are infected by the age of 5, with reinfections occurring throughout life.
Symptoms can range from mild to severe and include:
Symptoms may progress to bronchitis or pneumonia similar to other viruses that cause upper and lower respiratory tract infections.
The exact causes of HMPV are not fully known. However, some factors contribute to the risk of infection such as:
The HPMV predominantly affects young children (mostly under the age of 5 years), elderly people, individuals with weakened immune systems, and individuals suffering from chronic illnesses such as asthma, COPD, or heart diseases.
Complications of Human Metapneumovirus(HMPV) infection include:
A physical exam is performed to evaluate the symptoms. A laboratory test like PCR or a rapid antigen test is performed by taking swabs from the nose, mouth, or throat to identify the causative virus. In case of severe symptoms, a bronchoscopy may be ordered. In bronchoscopy, a thin tube with a tiny camera is inserted into the throat to collect the fluid. The fluid is then sent for testing for the virus.
There is no specific antiviral treatment for HMPV. Supportive therapy includes:
Seek medical attention if you or your child experience:
There is currently no vaccine for HMPV.
Although there is no specific treatment or vaccine for HMPV, supportive care and preventive measures like good hygiene and avoiding close contact with infected individuals can help manage and reduce its spread. Prompt medical attention is crucial for high-risk individuals showing severe symptoms.
Human Metapneumovirus (HMPV) is transmitted through:
Close personal contact, such as shaking hands or hugging, also increases the risk of transmission.
HMPV and COVID-19 are both respiratory viruses, but they are caused by different pathogens. HMPV belongs to the Paramyxoviridae family, while COVID-19 is caused by the SARS-CoV-2 virus in the Coronaviridae family. They share some common symptoms, such as fever and cough, but HMPV generally has less severe outcomes compared to COVID-19.
Yes, HMPV is highly contagious and spreads easily through respiratory droplets, direct contact with an infected person, and contaminated surfaces.
Mild cases of HMPV typically last 7–10 days. Severe cases, especially in vulnerable populations like young children, elderly people, and immunocompromised patients, may persist longer and require additional medical care.
Recovery involves supportive care:
HMPV can affect people of all ages, but it is most common and severe in:
No, antibiotics are ineffective against HMPV because it is a viral infection. Antibiotics may be prescribed only if there is a secondary bacterial infection, such as pneumonia.
Currently, there is no vaccine known for HMPV. Preventive measures, such as good hygiene and avoiding contact with sick individuals, are essential.
Most people recover within 7 to 10 days, depending on the severity of the infection and the individual’s overall health.
Yes, fever is a common symptom of HMPV in children, often accompanied by cough, runny nose, and difficulty breathing in more severe cases.
Lung Cancer Screening: Purpose, Preparation, Procedure and Eligibility
6 January 2025
6 January 2025
24 December 2024
24 December 2024
24 December 2024
19 November 2024
19 November 2024
19 November 2024
If you cannot find answers to your queries, please fill out the enquiry form or call the number below. We will contact you shortly.